Makris Susan L, Thompson Chad M, Euling Susan Y, Selevan Sherry G, Sonawane Babasaheb
National Center for Environmental Assessment (NCEA), Office of Research and Development (ORD), U.S. Environmental Protection Agency (USEPA), 1200 Pennsylvania Avenue, NW, Washington, DC 20460, USA.
Birth Defects Res B Dev Reprod Toxicol. 2008 Dec;83(6):530-46. doi: 10.1002/bdrb.20176.
In 2006, the U.S. EPA published a report entitled A Framework for Assessing Health Risks of Environmental Exposures to Children (hereafter referred to as the "Framework") describing a lifestage approach to risk assessment that includes the evaluation of existing data from a temporal perspective (i.e., the timing of both the exposure and the outcome). This article summarizes the lifestage-specific issues discussed in the Framework related to the qualitative and the quantitative hazard and dose-response characterization. Lifestage-specific hazard characterization includes an evaluation of relevant human and experimental animal studies, focusing on the identification of critical windows of development (i.e., exposure intervals of maximum susceptibility) for observed outcomes, evaluation of differential exposure at individual lifestages, the relevance and impact of lifestage-specific toxicokinetic and toxicodynamic data, mode of action information, variability and latency of effects from early lifestage exposure, and describing uncertainties. The interpretation of the hazard data to determine the strength of association between early life exposures and the timing and type of outcomes depends upon the overall weight of evidence. Lifestage-specific dose-response characterization relies on the identification of susceptible lifestages in order to quantify health risk, information on the point of departure, key default assumptions, and descriptions of uncertainty, sensitivity, and variability. Discussion of the strength and limitations of the hazard and dose-response data provides a basis for confidence in risk determinations. Applying a lifestage approach to hazard and dose-response characterization is likely to improve children's health risk assessment by identifying data gaps and providing a better understanding of sources of uncertainty.
2006年,美国环境保护局发布了一份题为《评估儿童环境暴露健康风险框架》(以下简称《框架》)的报告,该报告描述了一种风险评估的生命阶段方法,其中包括从时间角度(即暴露和结果的时间)评估现有数据。本文总结了《框架》中讨论的与定性和定量危害及剂量反应特征相关的特定生命阶段问题。特定生命阶段的危害特征包括对相关人体和实验动物研究的评估,重点是确定观察到的结果的关键发育窗口(即最大易感性的暴露间隔),评估个体生命阶段的差异暴露,特定生命阶段的毒代动力学和毒效学数据的相关性和影响,作用模式信息,早期生命阶段暴露影响的变异性和潜伏期,以及描述不确定性。对危害数据的解释以确定早期生命暴露与结果的时间和类型之间的关联强度取决于证据的总体权重。特定生命阶段的剂量反应特征依赖于确定易感生命阶段以量化健康风险、出发剂量信息、关键默认假设以及不确定性、敏感性和变异性的描述。对危害和剂量反应数据的优势和局限性的讨论为风险确定的信心提供了基础。将生命阶段方法应用于危害和剂量反应特征描述可能会通过识别数据差距并更好地理解不确定性来源来改善儿童健康风险评估。